Beyond conventional brachytherapy: a customized intracavitary approach for carcinoma cervix in an elderly patient

Prarabdh Singh; Siddharth Arora; Aditi Singh; Sudeep Chanda; Arjun Agarwal

doi:10.18203/2320-1770.ijrcog20264023

Authors

Prarabdh Singh Department of Radiation Oncology, Rohilkhand Medical College and Cancer Hospital, Bareilly, India
Siddharth Arora Department of Radiation Oncology, Rohilkhand Medical College and Cancer Hospital, Bareilly, India
Aditi Singh Department of Obstetrics and Gynecology Tirth Ram Shah Hospital, New Delhi, India
Sudeep Chanda Department of Medical Physics in Radiation Oncology, Rohilkhand Medical College and Cancer Hospital, Bareilly, India
Arjun Agarwal Department of surgical Oncology, Rohilkhand Medical College and Cancer hospital, Bareilly, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20264023

Keywords:

Cancer cervix, Brachytherapy tandem and cylinders, Dose-volume histogram, Intracavitary, Toxicity

Abstract

Brachytherapy remains cornerstone in treatment of gynaecological carcinoma for both definitive and adjuvant treatments. Due to rapid dose-gradient fall of brachytherapy, targets receive high dose with low dose to organ at risk and hence increasing tumor control. We present a rare case report of locally advanced case of Carcinoma cervix treated at our center with customised brachytherapy applicator comprising of tandem and cylinder. This application is simple and feasible in resource constraint setting offering similar local control and toxicity as compared to traditional Fletcher suit applicator. We Present a Case report of patient treated with this customised applicator with tandem and cylinder with acceptable toxicity and local control.

References

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49.

Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11(2).

Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340(15):1144-53.

Scott AA, Yarney J, Vanderpuye V, Aidoo CA, Agyeman M, Boateng SN, et al. Outcomes of patients with cervical cancer treated with low- or high-dose rate brachytherapy after concurrent chemoradiation. Int J Gynecol Cancer. 2021;31(5):670-8.

Podgorsak EB, editor. Radiation oncology physics: a handbook for teachers and students. Vienna: International Atomic Energy Agency; 2005.

Malik SR, Ahmed M, Reza MS, Bairagi AK, Yeasmin N, Banu PA, et al. HDR brachytherapy using cylinder, tandem-ovoid (T and O) and interstitial implant with prognosis. J Phys Conf Ser. 2021;1718:012016.

Lee JE, Huh SJ, Park W, Lim DH, Ahn YC, Park CS, et al. Radical radiotherapy for locally advanced cancer of uterine cervix. Cancer Res Treat. 2004;36(4):222-7.

Petereit DG, Frank SJ, Viswanathan AN, Erickson B, Eifel P, Nguyen PL, et al. Brachytherapy: where has it gone? J Clin Oncol. 2015;33(9):980-2.

International Commission on Radiation Units and Measurements. ICRU report 89: prescribing, recording, and reporting brachytherapy for cancer of the cervix. 2016. Available from: https://www.icru.org/report/icru-report-89-prescribing-recording-and-reporting-brachytherapy-for-cancer-of-the-cervix/ Accessed on 09 August 2026.

Logsdon MD, Eifel PJ. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys. 1999;43(4):763-75.

Glaser SM, Mohindra P, Mahantshetty U, Beriwal S. Complications of intracavitary brachytherapy for gynecologic cancers and their management: a comprehensive review. Brachytherapy. 2021;20(5):984-94.

Ahmed I, Kotur S, Sahoo DP, Marane S. Intravaginal cylinder brachytherapy with or without tandem in patients with carcinoma cervix not feasible for standard Fletcher-Suit-Delclos application. Brachytherapy. 2016;15 Suppl:S131–2.

Sahli N, Bakkali H, Boutayeb S, Khalil J, Elmajjaoui S, Elkacemi H, et al. Impact of brachytherapy in the treatment of locally advanced cervical cancer: results from a single institution. Gynecol Obstet (Sunnyvale). 2016;6:386.

Romano KD, Hill C, Trifiletti DM, Peach MS, Horton BJ, Shah N, et al. High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events. Radiat Oncol. 2018;13:129.

Mazeron R, Fokdal LU, Kirchheiner K, Georg P, Jastaniyah N, Šegedin B, et al. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: results from the prospective multicenter EMBRACE study. Radiother Oncol. 2016;120(3):412-9.

Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, et al. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (less than 4 cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2). Int J Radiat Oncol Biol Phys. 2012;82(1):e49-56.

Gadda IR, Khan NA, Wani SQ, Baba MH. To evaluate the use of tandem and cylinder as an intracavitary brachytherapy device for carcinoma of the cervix with regard to local control and toxicities. J Cancer Res Ther. 2022;18(3):740-6.